Drug Pipeline

Folfirinox Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
2
Recruiting
1
Phase 3
4
Top Sponsors
Active Studies by Phase
Phase 3
1
Phase 2
1
Phase 1/2
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07340567 Personalizing Chemotherapy Selection After Surgery for Patients With Stage III Colorectal… Colorectal Cancer Not Yet Recruiting
Phase 2
NCT04594772 Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic… Pancreas Cancer Active, Not Recruiting
Phase 1/2
NCT06384560 Neoadjuvant Triple Therapy for (Borderline) Resectable Pancreatic Cancer (PREOPANC-5) Localized Pancreatic Adenocarcinoma Recruiting
NCT06483555 Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel Pancreatic Adenocarcinoma Recruiting
Sponsors Running Folfirinox Trials
University of Cincinnati (1) Amsterdam UMC, location VUmc (1) UNC Lineberger Comprehensive Cancer Center (1) UNICANCER (1)
Disease Areas
Pancreatic Cancer (1) Colorectal Cancer (1)
Get alerts when Folfirinox trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free